Renaissance
Generated 5/9/2026
Executive Summary
Renaissance Lakewood, LLC is a US-based contract development and manufacturing organization (CDMO) specializing in complex nasal spray and sterile injectable dosage forms. Founded in 2020 and headquartered in New York, the company offers a comprehensive 'bench-to-shelf' service encompassing R&D, analytical testing, aseptic fill-finish, and packaging. Its focus on niche delivery systems positions it as a strategic partner for pharmaceutical clients seeking expertise in nasal drug delivery and sterile liquid manufacturing. Despite being early-stage, Renaissance has achieved approval status, indicating its facilities and processes meet regulatory standards. The CDMO market for nasal sprays and injectables is growing, driven by demand for biologics and self-administered therapies, providing Renaissance with opportunities to capitalize on outsourcing trends.
Upcoming Catalysts (preview)
- Q4 2026New Client Contract for Nasal Spray Development65% success
- Q3 2026Facility Expansion to Increase Aseptic Fill-Finish Capacity70% success
- Q4 2026Strategic Partnership with a Mid-Size Pharma for Sterile Injectables55% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)